We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

StemCells, Inc. Reports First Quarter Financial Results and Announces Reduction in Force

News   May 06, 2011

 
StemCells, Inc. Reports First Quarter Financial Results and Announces Reduction in Force
 
 
Advertisement
 

RELATED ARTICLES

Glutathione Precursor Improves Conditions Associated With Premature Aging in HIV Patients

News

An open-label clinical trial found that a glutathione precursor, GlyNAC, reverses premature aging in people with HIV.

READ MORE

NIH Study Designed To Identify Promising COVID-19 Treatments for Larger Clinical Trials

News

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapeutics or investigational drugs in late clinical development show promise against COVID-19 and warrant advancement into larger clinical trials.

READ MORE

Researchers Use Lab-Grown Tissue Grafts for Personalized Joint Replacement

News

A team led by Columbia Engineering has bioengineered anatomically precise living grafts for personalized replacement of a jaw joint, using the recipient's fat-derived cells, and demonstrated effectiveness in a clinically sized swine model.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE